Table 5. The influence of anti-glaucoma drugs on the levels of cytokines.
| Cytokine | No-drugs (n = 11) | Combined (n = 15) | Prostaglandin (n = 14) | P value* |
|---|---|---|---|---|
| G-CSF | 1.0 (1.3) | 0.7 (1.4) | 1.7 (9.1) | 0.298 |
| IL-6 | 1.6 (3.2) | 1.5 (1.1) | 4.2 (15.9) | 0.106 |
| IL-8 | 4.6 (3.2) | 5.8 (5.3) | 8.7 (7.1) | 0.136 |
| MCP-1 | 710.0 (644.0) | 895.0 (361.0) | 1042.5 (713.0) | 0.290 |
| MCP-3 | 3.2 (2.7) | 3.2 (2.1) | 4.2 (1.3) | 0.461 |
| MDC | 27.5 (19.7) | 43.1 (24.1) | 30.5 (37.7) | 0.458 |
| MIP-1β | 7.5 (10.1) | 2.9 (4.9) | 10.1 (11.8) | 0.023 |
| VEGF | 99.3 (164.0) | 94.8 (70.3) | 116.5 (107.0) | 0.575 |
Combined: other anti-glaucoma drugs exclude the prostaglandin.
Data are expressed as the median(interquartile range), pg/ml.
*
Kruskal–Wallis test was performed to compare the three groups.